Join us at Digital Pharma Europe in London May 17-19, 2017 in London where Dr. Alexandra V. Eberhard, Managing Director EMEA for Signals Analytics, will discuss "Using Signals Intelligence to Align with the Treatment Decision Journey and Patient Desired Outcomes".
Visit the event's site for more details.
Dr. Alexandra V. Eberhard
Managing Director EMEA
Prior to joining Signals Analytics, Alexandra was a Partner at Cukierman & Co. Life Sciences, leading business development, fundraising and M&A initiatives. She also previously served as the Chief Executive Officer of Recogene, a biotechnology company engaged in the development of an asymmetric-specific-recombination technology platform utilized for the development of genetic disease therapies. Alexandra holds a PhD in Immunology/Virology from BioMerieux, completed her post-doctorate at the Weizmann Institute of Science and earned an MBA from Bar Ilan University. She has co-authored more than 15 peer-reviewed international publications and received 6 academic awards.